These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Colorectal cancer in inflammatory bowel disease]. Henriksen M; Moum B Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2696-9. PubMed ID: 17952155 [TBL] [Abstract][Full Text] [Related]
4. 5-ASA and colorectal cancer chemoprevention in inflammatory bowel disease: can we afford to wait for 'best evidence'? Giannini EG; Kane SV; Testa R; Savarino V Dig Liver Dis; 2005 Oct; 37(10):723-31. PubMed ID: 16023905 [TBL] [Abstract][Full Text] [Related]
5. Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow. Ryan BM; Russel MG; Langholz E; Stockbrugger RW Am J Gastroenterol; 2003 Aug; 98(8):1682-7. PubMed ID: 12907319 [TBL] [Abstract][Full Text] [Related]
6. Chemoprevention for colon cancer: new opportunities, fact or fiction? Terhaar Sive Droste JS; Tuynman JB; Van Dullemen HM; Mulder CJ Scand J Gastroenterol Suppl; 2006; (243):158-64. PubMed ID: 16782636 [TBL] [Abstract][Full Text] [Related]
7. Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid. Bernstein CN; Eaden J; Steinhart AH; Munkholm P; Gordon PH Inflamm Bowel Dis; 2002 Sep; 8(5):356-61. PubMed ID: 12479651 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota. Jess T; Loftus EV; Velayos FS; Winther KV; Tremaine WJ; Zinsmeister AR; Scott Harmsen W; Langholz E; Binder V; Munkholm P; Sandborn WJ Am J Gastroenterol; 2007 Apr; 102(4):829-36. PubMed ID: 17222314 [TBL] [Abstract][Full Text] [Related]
10. Will a 5-ASA a day keep the cancer (and dysplasia) away? Rubin DT; Lashner BA Am J Gastroenterol; 2005 Jun; 100(6):1354-6. PubMed ID: 15929769 [TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a clinical review and update. Rubin DT; Cruz-Correa MR; Gasche C; Jass JR; Lichtenstein GR; Montgomery EA; Riddell RH; Rutter MD; Ullman TA; Velayos FS; Itzkowitz S; Inflamm Bowel Dis; 2008 Feb; 14(2):265-74. PubMed ID: 17932965 [TBL] [Abstract][Full Text] [Related]
12. Chemoprevention: risk reduction with medical therapy of inflammatory bowel disease. Chan EP; Lichtenstein GR Gastroenterol Clin North Am; 2006 Sep; 35(3):675-712. PubMed ID: 16952746 [TBL] [Abstract][Full Text] [Related]
13. Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel disease. Stange EF Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():64-7. PubMed ID: 16961748 [TBL] [Abstract][Full Text] [Related]
14. Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease. van Schaik FD; van Oijen MG; Smeets HM; van der Heijden GJ; Siersema PD; Oldenburg B Gut; 2012 Feb; 61(2):235-40. PubMed ID: 21602529 [TBL] [Abstract][Full Text] [Related]
15. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis. Qiu X; Ma J; Wang K; Zhang H Oncotarget; 2017 Jan; 8(1):1031-1045. PubMed ID: 27906680 [TBL] [Abstract][Full Text] [Related]
16. [Primary chemoprevention of colorectal cancer in patients with inflammatory bowel diseases]. Ioffe AIu Lik Sprava; 2005 Jun; (4):45-8. PubMed ID: 16158715 [TBL] [Abstract][Full Text] [Related]
17. [5-aminosalicylates and colorectal cancer: preventive role in chronic inflammatory bowel disease?]. Desreumaux P; Romano O Gastroenterol Clin Biol; 2004 May; 28(5):509. PubMed ID: 15243337 [No Abstract] [Full Text] [Related]
18. The prevention of colitis-related cancer by 5-aminosalicylates: an appealing hypothesis that remains unproven. Terdiman JP Am J Gastroenterol; 2011 Apr; 106(4):737-40. PubMed ID: 21468069 [TBL] [Abstract][Full Text] [Related]
19. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease. Torres J; Pineton de Chambrun G; Itzkowitz S; Sachar DB; Colombel JF Aliment Pharmacol Ther; 2011 Sep; 34(5):497-508. PubMed ID: 21692821 [TBL] [Abstract][Full Text] [Related]
20. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study. Bernstein CN; Nugent Z; Blanchard JF Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]